Prudential Financial’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-61,460
| Closed | -$175K | – | 2741 |
|
|
2024
Q2 | $175K | Sell |
61,460
-11,400
| -16% | -$32.5K | ﹤0.01% | 2496 |
|
|
2024
Q1 | $309K | Sell |
72,860
-16,700
| -19% | -$70.8K | ﹤0.01% | 2329 |
|
|
2023
Q4 | $479K | Sell |
89,560
-4,000
| -4% | -$21.4K | ﹤0.01% | 2148 |
|
|
2023
Q3 | $402K | Buy |
93,560
+78,100
| +505% | +$336K | ﹤0.01% | 2160 |
|
|
2023
Q2 | $84.9K | Buy |
+15,460
| New | +$84.9K | ﹤0.01% | 2491 |
|
|
2022
Q3 | – | Sell |
-10,200
| Closed | -$37K | – | 2677 |
|
|
2022
Q2 | $37K | Buy |
+10,200
| New | +$37K | ﹤0.01% | 2587 |
|
|
2021
Q4 | – | Sell |
-13,135
| Closed | -$92K | – | 2659 |
|
|
2021
Q3 | $92K | Sell |
13,135
-374
| -3% | -$2.62K | ﹤0.01% | 2535 |
|
|
2021
Q2 | $113K | Buy |
+13,509
| New | +$113K | ﹤0.01% | 2492 |
|